One dose of covaccine produces antibodies as much as two doses, claims ICMR study

If one dose of Bharat Biotech’s anti-Covid vaccine, Covaccine, was given to a person who had previously been infected with the corona virus, he would be given two doses.
The amount of antibodies that the dose elicits. This has been revealed in a study by the Indian Council of Medical Research (ICMR).

The study was published in the Indian Journal of Medical Research on Saturday. That said, in studies conducted among the wider population, our
If preliminary findings are confirmed, a single dose of BBV152 vaccine may be recommended to individuals already infected with SARS-CoV-2.
can. So that more people can take advantage of the limited vaccine supply. Covaccine, codenamed for India’s first indigenous anti-Covid-19 vaccine, is BBV 152.
Two doses are given with an interval of four to six weeks.

Research done on 114 people


The study was conducted in healthcare workers as well as frontline workers to test for SARS-CoV-2 specific antibody response. in this
The antibody response was compared with that of individuals in whom the infection was not confirmed. in Chennai from February to May 2021 in the study
Blood samples were collected from 114 healthcare workers and frontline workers receiving the vaccine at the vaccination centres.


Overall, a good antibody response was seen in those previously infected with SARS-CoV-2, the study said.
Took the first dose. It was similar to the antibodies found in people who had taken both doses and had not previously been infected with the virus.


Show More

Related Articles

Leave a Reply

Back to top button